Transfusion-associated hazards: A revisit of their presentation
Tóm tắt
Từ khóa
Tài liệu tham khảo
WH Organization, 2016
Nair, 2015, Repeat voluntary non-remunerated blood donor is the best quality indicator for blood safety, Indian J Med Res, 141, 749, 10.4103/0971-5916.160687
Eichbaum, 2016, Patient blood management: an international perspective, Anesth Analg, 123, 1574, 10.1213/ANE.0000000000001597
Mafirakureva, 2015, Profiles of blood and blood component transfusion recipients in Zimbabwe, Blood Transfus, 13, 600
Shander, 2007, Estimating the cost of blood: past, present, and future directions, Best Pract Res Clin Anaesthesiol, 21, 271, 10.1016/j.bpa.2007.01.002
Oge, 2014, Economic impact of blood transfusions: balancing cost and benefits, Eurasian J Med, 46, 47, 10.5152/eajm.2014.08
ANSM, 2017
Garraud, 2016, The infectious risks in blood transfusion as of today – a no black and white situation, Presse Med, 45, e303, 10.1016/j.lpm.2016.06.022
Califf, 2017, Balancing the need for access with the imperative for empirical evidence of benefit and risk, JAMA, 318, 614, 10.1001/jama.2017.9412
de Vries, 2011, Haemovigilance: an effective tool for improving transfusion practice, Vox Sang, 100, 60, 10.1111/j.1423-0410.2010.01442.x
Williamson, 2000, The serious hazards of transfusion (SHOT) initiative: the UK approach to haemovigilance, Vox Sang, 78, 291
Debeir, 1999, The French haemovigilance system, Vox Sang, 77, 77, 10.1046/j.1423-0410.1999.7720077.x
Savage, 2016, Transfusion reactions, Hematol Oncol Clin North Am, 30, 619, 10.1016/j.hoc.2016.01.012
Delaney, 2016, Transfusion reactions: prevention, diagnosis, and treatment, Lancet, 388, 2825, 10.1016/S0140-6736(15)01313-6
Dasararaju, 2015, Adverse effects of transfusion, Cancer Control, 22, 16, 10.1177/107327481502200104
Frazier, 2017, Adverse reactions to transfusion of blood products and best practices for prevention, Crit Care Nurs Clin North Am, 29, 271, 10.1016/j.cnc.2017.04.002
Vichinsky, 1990, Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood, N Engl J Med, 322, 1617, 10.1056/NEJM199006073222301
Kormoczi, 2014, Responder individuality in red blood cell alloimmunization, Transfus Med Hemother, 41, 446, 10.1159/000369179
Yazdanbakhsh, 2015, Mechanisms of sickle cell alloimmunization, Transfus Clin Biol, 22, 178, 10.1016/j.tracli.2015.05.005
Seftel, 2004, Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness, Blood, 103, 333, 10.1182/blood-2003-03-0940
Andreu, 2015, [Blood components and good practices in transfusion], Presse Med, 44, 165, 10.1016/j.lpm.2014.06.032
Pape, 2009, Clinical evidence of blood transfusion effectiveness, Blood Transfus, 7, 250
David, 2016, [Use of thrombelastography to guide posttraumatic hemostatic therapy: more coagulation factor concentrates and less allogenic blood transfusion?], Transfus Clin Biol, 23, 205, 10.1016/j.tracli.2016.07.002
Eisenstaedt, 1996
Stowell, 2017, The decision to transfuse: one size might not fit all, Crit Care Med, 45, 908, 10.1097/CCM.0000000000002383
Sharma, 2011, Transfusion of blood and blood products: indications and complications, Am Fam Physician, 83, 719
Popovsky, 2011
Sahu, 2014, Adverse events related to blood transfusion, Indian J Anaesth, 58, 543, 10.4103/0019-5049.144650
Osterman, 2014, Blood product transfusions and reactions, Emerg Med Clin North Am, 32, 727, 10.1016/j.emc.2014.04.012
Szczepiorkowski, 2013, Transfusion guidelines: when to transfuse, Hematology Am Soc Hematol Educ Program, 2013, 638, 10.1182/asheducation-2013.1.638
Franchini, 2014, Quality of transfusion products in blood banking, Semin Thromb Hemost, 40, 227, 10.1055/s-0034-1365840
Politis, 2016, The International haemovigilance network database for the surveillance of adverse reactions and events in donors and recipients of blood components: technical issues and results, Vox Sang, 111, 409, 10.1111/vox.12447
Réseau d’alerte diedsdin, 2013
Wiersum-Osselton, 2014, Definitions in haemovigilance: guiding principles and current state of development of international reference definitions, ISBT Sci Ser, 9, 91, 10.1111/voxs.12091
Poder, 2016, Effect of warming and flow rate conditions of blood warmers on red blood cell integrity, Vox Sang, 111, 341, 10.1111/vox.12423
Holland, 1997, Consent for transfusion: is it informed?, Transfus Med Rev, 11, 274, 10.1016/S0887-7963(97)80093-4
Di Minno, 2017, Pathogen reduction/inactivation of products for the treatment of bleeding disorders: what are the processes and what should we say to patients?, Ann Hematol, 96, 1253, 10.1007/s00277-017-3028-4
Friedman, 2012, Informed consent for blood transfusion: what do medicine residents tell? What do patients understand?, Am J Clin Pathol, 138, 559, 10.1309/AJCP2TN5ODJLYGQR
Vossoughi, 2015, Attitudes, practices, and training on informed consent for transfusions and procedures: a survey of medical students and physicians, Am J Clin Pathol, 144, 315, 10.1309/AJCPP85EXSGZORYZ
Milligan, 2016, Performance comparison of improvised prehospital blood warming techniques and a commercial blood warmer, Injury, 47, 1824, 10.1016/j.injury.2016.05.038
Vraets, 2011, Transfusion-associated hyperkalemia, Transfus Med Rev, 25, 184, 10.1016/j.tmrv.2011.01.006
Smith, 2008, Cardiac arrests associated with hyperkalemia during red blood cell transfusion: a case series, Anesth Analg, 106, 1062, 10.1213/ane.0b013e318164f03d
Bolton-Maggs, 2016, SHOT conference report 2016: serious hazards of transfusion – human factors continue to cause most transfusion-related incidents, Transfus Med, 26, 401, 10.1111/tme.12380
Laperche, 2015, [Blood transfusion: control of infectious risks], Presse Med, 44, 189, 10.1016/j.lpm.2014.06.034
Maurer-Spurej, 2007, Past and future approaches to assess the quality of platelets for transfusion, Transfus Med Rev, 21, 295, 10.1016/j.tmrv.2007.05.005
Ramirez-Arcos, 2017, Residual risk of bacterial contamination of platelets: six years of experience with sterility testing, Transfusion, 57, 2174, 10.1111/trf.14202
Swissmedic, 2015
Magron, 2017, Pathogen reduction technologies: the pros and cons for platelet transfusion, Platelets, 1
Morel, 2013, [Control of the bacterial risk of transfusion in France in 2013], Transfus Clin Biol, 20, 174, 10.1016/j.tracli.2013.03.007
Hechler, 2013, Preserved functional and biochemical characteristics of platelet components prepared with amotosalen and ultraviolet A for pathogen inactivation, Transfusion, 53, 1187, 10.1111/j.1537-2995.2012.03923.x
Schrezenmeier, 2010, Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred?, Vox Sang, 99, 1, 10.1111/j.1423-0410.2009.01295.x
Berger, 2016, Blood product supply in Germany: the impact of apheresis and pooled platelet concentrates, Transfus Med Hemother, 43, 389, 10.1159/000445442
Daurat, 2016, Apheresis platelets are more frequently associated with adverse reactions than pooled platelets both in recipients and in donors: a study from French hemovigilance data, Transfusion, 56, 1295, 10.1111/trf.13475
Britt, 2015, Controversies in the natural history of congenital human cytomegalovirus infection: the paradox of infection and disease in offspring of women with immunity prior to pregnancy, Med Microbiol Immunol, 204, 263, 10.1007/s00430-015-0399-9
Wilkinson, 2015, Human cytomegalovirus: taking the strain, Med Microbiol Immunol, 204, 273, 10.1007/s00430-015-0411-4
Barjas-Castro, 2016, Probable transfusion-transmitted Zika virus in Brazil, Transfusion, 56, 1684, 10.1111/trf.13681
Motta, 2016, Evidence for transmission of Zika virus by platelet transfusion, N Engl J Med, 375, 1101, 10.1056/NEJMc1607262
Pozzetto, 2016, [New viral risks in blood transfusion by 2016], Transfus Clin Biol, 23, 20, 10.1016/j.tracli.2015.12.004
Velati, 2017, State of the art: Vest Nile Virus circulation surveillance in Italy and transfusion risk early prevention methods, Transfus Clin Biol, 24, 172, 10.1016/j.tracli.2017.06.019
Groner, 2008, Pathogen safety of plasma-derived products – Haemate P/Humate-P, Haemophilia, 14, 54, 10.1111/j.1365-2516.2008.01852.x
Drew, 2017, Towards pathogen inactivation of red blood cells and whole blood targeting viral DNA/RNA: design, technologies, and future prospects for developing countries, Blood Transfus, 15, 512
Izopet, 2017, HEV and transfusion-recipient risk, Transfus Clin Biol, 24, 176, 10.1016/j.tracli.2017.06.012
Kumar, 2017, Time to consider cytomegalovirus prevention in critically ill patients?, JAMA, 318, 709, 10.1001/jama.2017.10132
Singh, 2010, Transfusion-transmitted parasitic infections, Asian J Transfus Sci, 4, 73, 10.4103/0973-6247.67018
O’Brien, 2015, The epidemiology of imported malaria and transfusion policy in 5 nonendemic countries, Transfus Med Rev, 29, 162, 10.1016/j.tmrv.2015.03.004
Abdullah, 2016, Malaria and blood transfusion: major issues of blood safety in malaria-endemic countries and strategies for mitigating the risk of Plasmodium parasites, Parasitol Res, 115, 35, 10.1007/s00436-015-4808-1
Angheben, 2015, Chagas disease and transfusion medicine: a perspective from non-endemic countries, Blood Transfus, 13, 540
Jimenez-Marco, 2017, The effectiveness of riboflavin and ultraviolet light pathogen reduction technology in eliminating Trypanosoma cruzi from leukoreduced whole blood, Transfusion, 57, 1440, 10.1111/trf.14071
Levin, 2016, Transfusion-transmitted babesiosis: is it time to screen the blood supply?, Curr Opin Hematol, 23, 573, 10.1097/MOH.0000000000000287
Herwaldt, 2011, Transfusion-associated babesiosis in the United States: a description of cases, Ann Intern Med, 155, 509, 10.7326/0003-4819-155-8-201110180-00362
Lefrere, 2009, From mad cows to sensible blood transfusion: the risk of prion transmission by labile blood components in the United Kingdom and in France, Transfusion, 49, 797, 10.1111/j.1537-2995.2008.02044.x
Llewelyn, 2004, Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion, Lancet, 363, 417, 10.1016/S0140-6736(04)15486-X
Hewitt, 2006, Creutzfeldt-Jakob disease and blood transfusion: results of the UK transfusion medicine epidemiological review study, Vox Sang, 91, 221, 10.1111/j.1423-0410.2006.00833.x
Urwin, 2016, Creutzfeldt-Jakob disease and blood transfusion: updated results of the UK transfusion medicine epidemiology review study, Vox Sang, 110, 310, 10.1111/vox.12371
Crowder, 2017, Creutzfeldt-Jakob disease lookback study: 21 years of surveillance for transfusion transmission risk, Transfusion, 57, 1875, 10.1111/trf.14145
Bougard, 2016, Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob disease, Sci Transl Med, 8, 370ra182, 10.1126/scitranslmed.aag1257
Blumberg, 2010, An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions, Transfusion, 50, 2738, 10.1111/j.1537-2995.2010.02748.x
Lieberman, 2013, A retrospective review of patient factors, transfusion practices, and outcomes in patients with transfusion-associated circulatory overload, Transfus Med Rev, 27, 206, 10.1016/j.tmrv.2013.07.002
Roubinian, 2017, Incidence and clinical characteristics of transfusion-associated circulatory overload using an active surveillance algorithm, Vox Sang, 112, 56, 10.1111/vox.12466
Clifford, 2015, Characterizing the epidemiology of perioperative transfusion-associated circulatory overload, Anesthesiology, 122, 21, 10.1097/ALN.0000000000000513
Parmar, 2017, The association of fever with transfusion-associated circulatory overload, Vox Sang, 112, 70, 10.1111/vox.12473
Piccin, 2015, Transfusion-associated circulatory overload in Ireland: a review of cases reported to the National Haemovigilance Office 2000 to 2010, Transfusion, 55, 1223, 10.1111/trf.12965
Alam, 2013, The prevention of transfusion-associated circulatory overload, Transfus Med Rev, 27, 105, 10.1016/j.tmrv.2013.02.001
Roubinian, 2017, Differentiating pulmonary transfusion reactions using recipient and transfusion factors, Transfusion, 57, 1684, 10.1111/trf.14118
Menis, 2014, Transfusion-associated circulatory overload (TACO) and potential risk factors among the inpatient US elderly as recorded in Medicare administrative databases during 2011, Vox Sang, 106, 144, 10.1111/vox.12070
Sarai, 2015, Loop diuretics for patients receiving blood transfusions, Cochrane Database Syst Rev, CD010138
Li, 2015, Citrate metabolism in blood transfusions and its relationship due to metabolic alkalosis and respiratory acidosis, Int J Clin Exp Med, 8, 6578
Marsella, 2014, Transfusional iron overload and iron chelation therapy in thalassemia major and sickle cell disease, Hematol Oncol Clin North Am, 28, 10.1016/j.hoc.2014.04.004
Greenberg, 2006, Myelodysplastic syndromes: iron overload consequences and current chelating therapies, J Natl Compr Canc Netw, 4, 91, 10.6004/jnccn.2006.0010
Kleinman, 2004, Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel, Transfusion, 44, 1774, 10.1111/j.0041-1132.2004.04347.x
Bernard, 2017, Acute lung failure – our evolving understanding of ARDS, N Engl J Med, 377, 507, 10.1056/NEJMp1706595
Toy, 2017, Proposed revised nomenclature for transfusion-related acute lung injury, Transfusion, 57, 709, 10.1111/trf.13944
Vlaar, 2013, Transfusion-related acute lung injury: a clinical review, Lancet, 382, 984, 10.1016/S0140-6736(12)62197-7
Toy, 2012, Transfusion-related acute lung injury: incidence and risk factors, Blood, 119, 1757, 10.1182/blood-2011-08-370932
Silliman, 2003, Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors, Blood, 101, 454, 10.1182/blood-2002-03-0958
Tariket, 2016, Transfusion-related acute lung injury: transfusion, platelets and biological response modifiers, Expert Rev Hematol, 9, 497, 10.1586/17474086.2016.1152177
Peters, 2015, Antibody-mediated transfusion-related acute lung injury; from discovery to prevention, Br J Haematol, 170, 597, 10.1111/bjh.13459
Otrock, 2017, Transfusion-related acute lung injury risk mitigation: an update, Vox Sang, 112, 694, 10.1111/vox.12573
Andreu, 2017, Analysis of transfusion-related acute lung injury and possible transfusion-related acute lung injury reported to the french hemovigilance network from 2007 to 2013, Transfus Med Rev, 32, 16, 10.1016/j.tmrv.2017.07.001
Silliman, 2014, Experimental prestorage filtration removes antibodies and decreases lipids in RBC supernatants mitigating TRALI in vivo, Blood, 123, 3488, 10.1182/blood-2013-10-532424
Winter, 2014, Red blood cell in vitro quality and function is maintained after S-303 pathogen inactivation treatment, Transfusion, 54, 1798, 10.1111/trf.12545
Gephart, 2012, Transfusion-associated necrotizing enterocolitis: evidence and uncertainty, Adv Neonatal Care, 12, 232, 10.1097/ANC.0b013e31825e20ee
Bailey, 2015, Variability in splanchnic tissue oxygenation during preterm red blood cell transfusion given for symptomatic anaemia may reveal a potential mechanism of transfusion-related acute gut injury, Blood Transfus, 13, 429
La Gamma, 2012, Transfusion-related acute gut injury: feeding, flora, flow, and barrier defense, Semin Perinatol, 36, 294, 10.1053/j.semperi.2012.04.011
Blau, 2011, Transfusion-related acute gut injury: necrotizing enterocolitis in very low birth weight neonates after packed red blood cell transfusion, J Pediatr, 158, 403, 10.1016/j.jpeds.2010.09.015
Kopolovic, 2015, A systematic review of transfusion-associated graft-versus-host disease, Blood, 126, 406, 10.1182/blood-2015-01-620872
Jawa, 2015, Transfusion-associated graft versus host disease in the immunocompetent patient: an ongoing problem, J Intensive Care Med, 30, 123, 10.1177/0885066613492645
Gokhale, 2015, Transfusion-associated graft versus host disease (TAGVHD) – with reference to neonatal period, J Matern Fetal Neonatal Med, 28, 700, 10.3109/14767058.2014.928859
Fast, 2012, Developments in the prevention of transfusion-associated graft-versus-host disease, Br J Haematol, 158, 563, 10.1111/j.1365-2141.2012.09197.x
Cid, 2017, Prevention of transfusion-associated graft-versus-host disease with pathogen-reduced platelets with amotosalen and ultraviolet A light: a review, Vox Sang, 112, 607, 10.1111/vox.12558
AABB, 2012
European Committee on Blood Transfusion, 2010
Asai, 2000, Guidelines for irradiation of blood and blood components to prevent post-transfusion graft-vs.-host disease in Japan, Transfus Med, 10, 315, 10.1046/j.1365-3148.2000.00264.x
Gehrie, 2016, Modifications to blood components: when to use them and what is the evidence?, Hematol Oncol Clin North Am, 30, 653, 10.1016/j.hoc.2016.01.007
Ruhl, 2009, Transfusion-associated graft-versus-host disease, Transfus Med Rev, 23, 62, 10.1016/j.tmrv.2008.09.006
Elemary, 2017, Transfusion challenges in hematology oncology and hematopoietic stem cell transplant – literature review and local experience, Transfus Apher Sci, 56, 317, 10.1016/j.transci.2017.05.022
Garraud, 2016, Transfusion as an inflammation hit: knowns and unknowns, Front Immunol, 7, 534, 10.3389/fimmu.2016.00534
Blumberg, 2006, An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions, Transfusion, 46, 1813, 10.1111/j.1537-2995.2006.00979.x
Andre, 2002, Platelet-derived CD40L: the switch-hitting player of cardiovascular disease, Circulation, 106, 896, 10.1161/01.CIR.0000028962.04520.01
Cognasse, 2006, Release of potential immunomodulatory factors during platelet storage, Transfusion, 46, 1184, 10.1111/j.1537-2995.2006.00869.x
Hamzeh-Cognasse, 2014, Immune-reactive soluble OX40 ligand, soluble CD40 ligand, and interleukin-27 are simultaneously oversecreted in platelet components associated with acute transfusion reactions, Transfusion, 54, 613, 10.1111/trf.12378
Garraud, 2013, Bench-to-bedside review: platelets and active immune functions – new clues for immunopathology?, Crit Care, 17, 236, 10.1186/cc12716
Nguyen, 2014, A computerized prediction model of hazardous inflammatory platelet transfusion outcomes, PloS One, 9, e97082, 10.1371/journal.pone.0097082
Cognasse, 2016, Platelet components associated with adverse reactions: predictive value of mitochondrial DNA relative to biological response modifiers, Transfusion, 56, 497, 10.1111/trf.13373
Aloui, 2016, Levels of human platelet-derived soluble CD40 ligand depend on haplotypes of CD40LG-CD40-ITGA2, Sci Rep, 6, 24715, 10.1038/srep24715
Aloui, 2014, Are polymorphisms of the immunoregulatory factor CD40LG implicated in acute transfusion reactions?, Sci Rep, 4, 7239, 10.1038/srep07239
Cognasse, 2017, Platelet soluble CD40-Ligand level is associated with transfusion adverse reactions in a mixed threshold and hit model, Blood, 130, 1380, 10.1182/blood-2017-03-773945
Rogers, 2015, Recent advances in preventing adverse reactions to transfusion, F1000Research, 4, 10.12688/f1000research.7048.1
van der Meer, 2016, PAS or plasma for storage of platelets? A concise review, Transfus Med, 26, 339, 10.1111/tme.12325
Cholette, 2012, Washing red blood cells and platelets transfused in cardiac surgery reduces postoperative inflammation and number of transfusions: results of a prospective, randomized, controlled clinical trial, Pediatr Crit Care Med, 13, 290, 10.1097/PCC.0b013e31822f173c
Tanaka, 2015, A hollow-fibre column system to effectively prepare washed platelets, Vox Sang, 109, 239, 10.1111/vox.12284
Cognasse, 2008, Release of immune modulation factors from platelet concentrates during storage after photochemical pathogen inactivation treatment, Transfusion, 48, 809, 10.1111/j.1537-2995.2008.01655.x
Novotny, 2007, Red cell transfusion in medicine: future challenges, Transfus Clin Biol, 14, 538, 10.1016/j.tracli.2008.01.001
Litvinov, 2017, Role of red blood cells in haemostasis and thrombosis, ISBT Sci Ser, 12, 176, 10.1111/voxs.12331
Garraud, 2017, Effect of “old” versus “fresh” transfused red blood cells on patients’ outcome: probably more complex than appears, J Thorac Dis, 9, E146, 10.21037/jtd.2017.02.03
Garraud, 2017, Clinical trials in transfusion medicine and hemotherapy: worth moving forward in evaluating “fresh” versus “old” blood cell components?, Transfus Apher Sci, 56, 98, 10.1016/j.transci.2016.12.030
Belpulsi, 2017, The controversy over the age of blood: what do the clinical trials really teach us?, Blood Transfus, 15, 112
Gehrie, 2018, A multicentre study investigating vital sign changes occurring in complicated and uncomplicated transfusions, Vox Sang, 113, 160, 10.1111/vox.12621
Hirayama, 2018, Possible utility of the basophil activation test for the analysis of mechanisms involved in allergic transfusion reactions, Transfus Med Rev, 32, 43, 10.1016/j.tmrv.2017.09.002
Hirayama, 2013, Current understanding of allergic transfusion reactions: incidence, pathogenesis, laboratory tests, prevention and treatment, Br J Haematol, 160, 434, 10.1111/bjh.12150
Savage, 2014, Defining risk factors and presentations of allergic reactions to platelet transfusion, J Allergy Clin Immunol, 133, 10.1016/j.jaci.2014.03.030
Savage, 2011, Allergic transfusion reactions to platelets are associated more with recipient and donor factors than with product attributes, Transfusion, 51, 1716, 10.1111/j.1537-2995.2010.03009.x
Savage, 2013, Scratching the surface of allergic transfusion reactions, Transfusion, 53, 1361, 10.1111/j.1537-2995.2012.03892.x
Kalra, 2012, Acute hypotensive transfusion reaction with concomitant use of angiotensin-converting enzyme inhibitors: a case report and review of the literature, Am J Ther, 19, e90, 10.1097/MJT.0b013e3181e4ddb2
Moreau, 2007, Generation of kinins during preparation and storage of whole blood-derived platelet concentrates, Transfusion, 47, 410, 10.1111/j.1537-2995.2007.01097.x
Sweeney, 1998, Hypotensive reactions to red cells filtered at the bedside, but not to those filtered before storage, in patients taking ACE inhibitors, Transfusion, 38, 410, 10.1046/j.1537-2995.1998.38498257382.x
Takahashi, 1995, Bradykinin generation during filtration of platelet concentrates with a white cell-reduction filter, Transfusion, 35, 967, 10.1046/j.1537-2995.1995.351196110903.x
Pagano, 2015, Hypotensive transfusion reactions in the era of prestorage leukoreduction, Transfusion, 55, 1668, 10.1111/trf.13047
Cyr, 2001, Bradykinin metabolism and hypotensive transfusion reactions, Transfusion, 41, 136, 10.1046/j.1537-2995.2001.41010136.x
Shtalrid, 2006, Post-transfusion purpura: a challenging diagnosis, Isr Med Assoc J, 8, 672
Padhi, 2013, Post-transfusion purpura: a rare and life-threatening aetiology of thrombocytopenia, BMJ Case Rep, 2013, 10.1136/bcr-2013-008860
Gonzalez, 2005, Post-transfusion purpura, Curr Hematol Rep, 4, 154
Bob, 1997, Trial to reduce alloimmunization to platelets study G. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions, N Engl J Med, 337, 1861, 10.1056/NEJM199712253372601
Slichter, 2017, Leukofiltration plus pathogen reduction prevents alloimmune platelet refractoriness in a dog transfusion model, Blood, 130, 1052, 10.1182/blood-2016-07-726901
Zimring, 2013, Fresh versus old blood: are there differences and do they matter?, Hematology Am Soc Hematol Educ Program, 2013, 651, 10.1182/asheducation-2013.1.651
Hod, 2008, Platelet transfusion refractoriness, Br J Haematol, 142, 348, 10.1111/j.1365-2141.2008.07189.x
Hendrickson, 2016, Understanding red blood cell alloimmunization triggers, Hematology Am Soc Hematol Educ Program, 2016, 446, 10.1182/asheducation-2016.1.446
Pavenski, 2012, HLA alloimmunization against platelet transfusions: pathophysiology, significance, prevention and management, Tissue Antigens, 79, 237, 10.1111/j.1399-0039.2012.01852.x
Zimring, 2016, Cellular immune responses in red blood cell alloimmunization, Hematology Am Soc Hematol Educ Program, 2016, 452, 10.1182/asheducation-2016.1.452
Gibb, 2016, The Nlrp3 inflammasome does not regulate alloimmunization to transfused red blood cells in mice, EBioMedicine, 9, 77, 10.1016/j.ebiom.2016.06.008
Cognasse, 2015, The inflammatory role of platelets via their TLRs and Siglec receptors, Front Immunol, 6, 83, 10.3389/fimmu.2015.00083
Ryder, 2014, Factors influencing RBC alloimmunization: lessons learned from murine models, Transfus Med Hemother, 41, 406, 10.1159/000368995
Zimring, 2015, Pathobiology of transfusion reactions, Annu Rev Pathol, 10, 83, 10.1146/annurev-pathol-012414-040318
Spitalnik, 2014, Stored red blood cell transfusions: iron, inflammation, immunity, and infection, Transfusion, 54, 2365, 10.1111/trf.12848
Silvy, 2014, Red blood cell immunization in sickle cell disease: evidence of a large responder group and a low rate of anti-Rh linked to partial Rh phenotype, Haematologica, 99, e115, 10.3324/haematol.2014.104703
Vingert, 2015, Phenotypic differences of CD4(+) T cells in response to red blood cell immunization in transfused sickle cell disease patients, Eur J Immunol, 45, 1868, 10.1002/eji.201445187
Pirenne, 2015, TIGIT-positive circulating follicular helper T cells and sickle cell alloimmunization, Haematologica, 100, 1371, 10.3324/haematol.2015.136135
Ziman, 2017, Warm-reactive (immunoglobulin G) autoantibodies and laboratory testing best practices: review of the literature and survey of current practice, Transfusion, 57, 463, 10.1111/trf.13903
Yazdanbakhsh, 2016, Immunoregulatory networks in sickle cell alloimmunization, Hematology Am Soc Hematol Educ Program, 2016, 457, 10.1182/asheducation-2016.1.457
Ryder, 2016, Chronic inflammatory autoimmune disorders are a risk factor for red blood cell alloimmunization, Br J Haematol, 174, 483, 10.1111/bjh.13781
Yazdanbakhsh, 2012, Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management, Blood, 120, 528, 10.1182/blood-2011-11-327361
Meinderts, 2017, Nonclassical FCGR2C haplotype is associated with protection from red blood cell alloimmunization in sickle cell disease, Blood, 130, 2121, 10.1182/blood-2017-05-784876
Habibi, 2016, Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes, Am J Hematol, 91, 989, 10.1002/ajh.24460
Nickeleit, 1998, The prognostic significance of specific arterial lesions in acute renal allograft rejection, Clin J Am Soc Nephrol, 9, 1301, 10.1681/ASN.V971301
Engels-Deutsch, 2011, Streptococcus mutans antigen I/II binds to alpha5beta1 integrins via its A-domain and increases beta1 integrins expression on periodontal ligament fibroblast cells, Arch Oral Biol, 56, 22, 10.1016/j.archoralbio.2010.08.010
Garraud, 2017, Linking transfusion and ecology is not so futile after all: a holistic reappraisal of transfusion and immunity, Transfus Clin Biol, 25, 81, 10.1016/j.tracli.2017.10.005
Sadana, 2017, Promoting high-value practice by reducing unnecessary transfusions with a patient blood management program, JAMA Int Med, 178, 116, 10.1001/jamainternmed.2017.6369